🟢 Cerenome is trading 6.5% up in pre-market with no identified catalyst

Cerenome is trading 6.5% up at $1.98 in pre-market on September 30, 2026; no new company announcement explaining the move was identified.

• A CNSide business update call was scheduled for 8:30 a.m. ET on September 30 to discuss billing, market access, commercial team expansion and testing portfolio plans; its advance notice reports no new result or confirmed link to the move.
• The September 22 Blue Cross Blue Shield of Michigan coverage agreement is prior news, not a clear catalyst for this morning’s gain.